# Mark Lebwohl Md

শীর্ষ পডকাস্ট এপিসোড
আপডেট করা হয়েছে:

Raising the Bar in Atopic Dermatitis: Where Are We Now?

In this episode of Derms and Conditions, host James Del Rosso, DO, speaks with Mark Lebwohl, MD, Dean for Clinical Therapeutics at the Icahn School of Medicine at Mount Sinai, about the role of Janus kinase (JAK) inhibitors, particularly upadacitinib, in treating atopic dermatitis. They provide ins…

Atopic Dermatitis: Connections Between Cytokine Inhibition and Clinical Outcomes

In episode 49 of Derms and Conditions, James Q. Del Rosso, DO and Mark Lebwohl, MD discussed the pathophysiology of atopic dermatitis and the role of cytokines in its management. Drs. Lebwohl and Del Rosso discussed how specific cytokines can be targeted for a safer treatment of atopic dermatitis. …

When Cryotherapy Alone Gets Too Cold: Topical Field Therapy for Actinic Keratoses

In episode 21 of Derms and Conditions, our host James Q. Del Rosso, DO speaks with Mark Lebwohl, MD, Dean for Clinical Therapeutics and Chairman Emeritus at Icahn School of Medicine at Mount Sinai. Dr. Lebwohl discusses field treatments of actinic keratosis (AK). He also discusses the benefits and …

S1 Ep30: Impact of the JAK Inhibitor Approval Delays

This episode takes a deep dive in the recent delay in approval for multiple JAK inhibitor drugs for treatment of inflammatory skin conditions such as psoriasis and atopic dermatitis. Mark Lebwohl, MD, discusses the impact of the delay, as well as the benefits of JAK inhibitors for inflammatory skin…

Kidney Disease Associated Pruritus: Sponsored by Cara Therapeutics

Mark Lebwohl, MD, FAAD, Sara Combs, MD, FAAD and J. Pedro Teixeira, MD, FAAD interviewed by Steven Chen, MD, FAAD This episode has been sponsored by Cara Therapeutics. View episode transcript

Episode 15 - Conversations in Psoriasis and Psoriatic Arthritis: Evolving Strategies in PsO and PsA: A Clinical Guide for Optimized Patient Care - Early Diagnosis and Screening/Managing Comorbidities Podcast - Part 2

Managing psoriasis (PsO) and psoriatic arthritis (PsA) presents multiple challenges for healthcare professionals, including staying up to date with emerging therapies, recognizing early signs of PsA, managing comorbidities, and implementing multidisciplinary care strategies. Despite advances in bio…

Episode 14 - Conversations in Psoriasis and Psoriatic Arthritis: Evolving Strategies in PsO and PsA: A Clinical Guide for Optimized Patient Care - Personalized Treatment Strategies Podcast - Part 1

Managing psoriasis (PsO) and psoriatic arthritis (PsA) presents multiple challenges for healthcare professionals, including staying up to date with emerging therapies, recognizing early signs of PsA, managing comorbidities, and implementing multidisciplinary care strategies. Despite advances in bio…

Episode 16 - Conversations in Psoriasis and Psoriatic Arthritis: Evolving Strategies in PsO and PsA: A Clinical Guide for Optimized Patient Care - Patient-Centered Care Podcast - Part 3

Managing psoriasis (PsO) and psoriatic arthritis (PsA) presents multiple challenges for healthcare professionals, including staying up to date with emerging therapies, recognizing early signs of PsA, managing comorbidities, and implementing multidisciplinary care strategies. Despite advances in bio…

COVID-19 Series: Skin Signs of Covid-19 Infection

Mark Lebwohl, MD; Lindy Fox, MD; Esther Freeman, MD; Raffaele Gianotti, MD interviewed by Shadi Kourosh, MD

New and Emerging Therapies

Mark Lebwohl, MD, discusses the new and emerging therapies for treatment of psoriasis, including: Can you elaborate on the different classes of biologics currently indicated for treatment of psoriasis? What are some of the most promising therapies that will likely be part of the psoriasis treat…